Y Intercept (Hong Kong) LTD Laboratory Corp Of America Holdings Transaction History

Y Intercept (Hong Kong) LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$209.01 - $232.56 $744,493 - $828,378	-3,562 Reduced 67.85%	1,688 $368,000
Q4 2023 Feb 13, 2024	BUY	$197.69 - $227.29 $1.04 Million - $1.19 Million	5,250 New	5,250 $1.19 Million
Q4 2022 Feb 14, 2023	SELL	$203.72 - $248.97 $4.05 Million - $4.95 Million	-19,884 Closed	0 $0
Q3 2022 Feb 14, 2023	BUY	$204.81 - $262.19 $4.07 Million - $5.21 Million	19,884 New	19,884 $4.07 Million
Q4 2021 Feb 14, 2022	SELL	$271.6 - $314.21 $586,384 - $678,379	-2,159 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$274.82 - $308.34 $593,336 - $665,706	2,159 New	2,159 $608,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.6B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.